1. Home
  2. POET vs LFMD Comparison

POET vs LFMD Comparison

Compare POET & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POET
  • LFMD
  • Stock Information
  • Founded
  • POET 1972
  • LFMD 1994
  • Country
  • POET Canada
  • LFMD United States
  • Employees
  • POET N/A
  • LFMD N/A
  • Industry
  • POET Semiconductors
  • LFMD Medical/Nursing Services
  • Sector
  • POET Technology
  • LFMD Health Care
  • Exchange
  • POET Nasdaq
  • LFMD Nasdaq
  • Market Cap
  • POET 479.0M
  • LFMD 535.4M
  • IPO Year
  • POET N/A
  • LFMD N/A
  • Fundamental
  • Price
  • POET $5.34
  • LFMD $6.11
  • Analyst Decision
  • POET Strong Buy
  • LFMD Buy
  • Analyst Count
  • POET 2
  • LFMD 6
  • Target Price
  • POET $6.25
  • LFMD $12.50
  • AVG Volume (30 Days)
  • POET 1.3M
  • LFMD 1.6M
  • Earning Date
  • POET 08-11-2025
  • LFMD 11-06-2025
  • Dividend Yield
  • POET N/A
  • LFMD N/A
  • EPS Growth
  • POET N/A
  • LFMD N/A
  • EPS
  • POET N/A
  • LFMD N/A
  • Revenue
  • POET $467,946.00
  • LFMD $245,563,670.00
  • Revenue This Year
  • POET $8,377.56
  • LFMD $21.50
  • Revenue Next Year
  • POET $1,061.73
  • LFMD $17.41
  • P/E Ratio
  • POET N/A
  • LFMD N/A
  • Revenue Growth
  • POET 302.50
  • LFMD 37.74
  • 52 Week Low
  • POET $2.63
  • LFMD $3.99
  • 52 Week High
  • POET $7.79
  • LFMD $15.84
  • Technical
  • Relative Strength Index (RSI)
  • POET 49.30
  • LFMD 34.37
  • Support Level
  • POET $5.03
  • LFMD $6.01
  • Resistance Level
  • POET $5.34
  • LFMD $6.36
  • Average True Range (ATR)
  • POET 0.28
  • LFMD 0.30
  • MACD
  • POET 0.02
  • LFMD 0.15
  • Stochastic Oscillator
  • POET 61.59
  • LFMD 27.12

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Share on Social Networks: